QIAGEN IPA

QIAGEN Ingenuity Pathway Analysis CaseStudy_CD155 Expression in Metastatic Melanoma and Anti-PD1 resistance

399 views
October 14, 2020
In this video, Eric Seiser, Ph.D, Sr. Field Application Scientist will be demonstrating a use case of QIAGEN Ingenuity Pathway Analysis for interpreting the biology of gene expression based omics dataset. The focus will be on a recent study on a potential therapeutic target CD155 for Metastatic Melanoma patients that demonstrate resistance to Anti-PD1 based therapies

Related videos

QIAGEN IPA

QIAGEN Ingenuity Pathway Analysis (IPA): Deep-dive trainings- July 21 2021

24 views July 22, 2021

As requested by many users, your QIAGEN Digital Insights team is excited to...

QIAGEN IPA

New user training: Large dataset analysis and knowledge base queries using QIAGEN Ingenuity...

38 views July 22, 2021

This 90-minute training session is for new users of QIAGEN IPA. Users will...

QIAGEN IPA

New user training: Large dataset analysis and knowledgebase queries using QIAGEN IPA- February 17

341 views February 20, 2021

In this 90-minute video, users will take a deeper dive into core analysis,...

QIAGEN IPA

New user training: Large dataset analysis and knowledgebase queries using QIAGEN IPA- February 16

330 views February 20, 2021

In this 90-minute video, new users will learn - how to upload their dataset...